399 related articles for article (PubMed ID: 25742381)
1. Infant and maternal characteristics in neonatal abstinence syndrome--selected hospitals in Florida, 2010-2011.
Lind JN; Petersen EE; Lederer PA; Phillips-Bell GS; Perrine CG; Li R; Hudak M; Correia JA; Creanga AA; Sappenfield WM; Curran J; Blackmore C; Watkins SM; Anjohrin S;
MMWR Morb Mortal Wkly Rep; 2015 Mar; 64(8):213-6. PubMed ID: 25742381
[TBL] [Abstract][Full Text] [Related]
2. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
[TBL] [Abstract][Full Text] [Related]
3. Identification of Substance-Exposed Newborns and Neonatal Abstinence Syndrome Using ICD-10-CM - 15 Hospitals, Massachusetts, 2017.
Goyal S; Saunders KC; Moore CS; Fillo KT; Ko JY; Manning SE; Shapiro-Mendoza C; Gupta M; Romero L; Coy KC; McDow KB; Keaton AA; Sinatra J; Jones K; Alpren C; Barfield WD; Diop H
MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):951-955. PubMed ID: 32701936
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Breastfeeding and Length of Hospital Stay Among Infants Diagnosed with Neonatal Abstinence Syndrome: A Population-Based Study of In-Hospital Births.
Short VL; Gannon M; Abatemarco DJ
Breastfeed Med; 2016 Sep; 11():343-9. PubMed ID: 27529500
[TBL] [Abstract][Full Text] [Related]
5. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
[TBL] [Abstract][Full Text] [Related]
6. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
7. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
8. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
Hussaini KS; Garcia Saavedra LF
Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
[TBL] [Abstract][Full Text] [Related]
9. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR
J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950
[TBL] [Abstract][Full Text] [Related]
10. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
McQueen KA; Murphy-Oikonen J; Desaulniers L
Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
[TBL] [Abstract][Full Text] [Related]
11. Maternal drug use and its effect on neonates: a population-based study in Washington State.
Creanga AA; Sabel JC; Ko JY; Wasserman CR; Shapiro-Mendoza CK; Taylor P; Barfield W; Cawthon L; Paulozzi LJ
Obstet Gynecol; 2012 May; 119(5):924-33. PubMed ID: 22525903
[TBL] [Abstract][Full Text] [Related]
12. Perinatal outcome of illicit substance use in pregnancy--comparative and contemporary socio-clinical profile in the UK.
Goel N; Beasley D; Rajkumar V; Banerjee S
Eur J Pediatr; 2011 Feb; 170(2):199-205. PubMed ID: 20827558
[TBL] [Abstract][Full Text] [Related]
13. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
[TBL] [Abstract][Full Text] [Related]
14. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources.
Dryden C; Young D; Hepburn M; Mactier H
BJOG; 2009 Apr; 116(5):665-71. PubMed ID: 19220239
[TBL] [Abstract][Full Text] [Related]
15. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
Gray TR; Choo RE; Concheiro M; Williams E; Elko A; Jansson LM; Jones HE; Huestis MA
Addiction; 2010 Dec; 105(12):2151-9. PubMed ID: 20854338
[TBL] [Abstract][Full Text] [Related]
16. Drivers of Hospital Length of Stay in Medicaid and Commercially Insured Mother-Infant Pairs With a Diagnosis of Neonatal Abstinence Syndrome.
Parlett L; Agiro A; Brown S; Wilt M; Portzline A; Verburg J; Shea K; DeVries A
Med Care; 2019 Dec; 57(12):977-983. PubMed ID: 31567861
[TBL] [Abstract][Full Text] [Related]
17. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
[TBL] [Abstract][Full Text] [Related]
18. Maternal methadone treatment and neonatal abstinence syndrome.
Liu WF; Singh K; Faisal M; Li S
Am J Perinatol; 2015 Sep; 32(11):1078-86. PubMed ID: 25915141
[TBL] [Abstract][Full Text] [Related]
19. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
[TBL] [Abstract][Full Text] [Related]
20. Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
Hirai AH; Ko JY; Owens PL; Stocks C; Patrick SW
JAMA; 2021 Jan; 325(2):146-155. PubMed ID: 33433576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
